Strategies to counteract ß-cell loss in pancreatic islet transplantation
Metadata
Show metadataAppears in the following Collection
- Institutt for klinisk medisin [10794]
Abstract
No abstract.List of papers
Paper I Lund T, Fosby B, Korsgren O, Scholz H, Foss A. Glucocorticoids reduce proinflammatory cytokines and tissue factor in vitro and improve function of transplanted human islets in vivo. Transplant International 2008; 21: 669-678. The paper is not available in DUO. The published version is available at: https://doi.org/10.1111/j.1432-2277.2008.00664.x |
Paper II Scholz H, Lund T, Dahle MK, Collins JL, Korsgren O, Wang JE, Foss A. The synthetic liver X receptor agonist GW3965 reduces tissue factor expression and inflammatory responses in human islets in vitro. Diabetologia accepted. The paper is not available in DUO. |
Paper III Lund T, Mangsbo SM, Scholz H, Totterman TH, Korsgren O, Foss A. Resolvin E1 reduces proinflammatory markers in human pancreatic islets in vitro. Experimental and Clinical Endocrinology & Diabetes accepted. The paper is not available in DUO. |
Paper IV Lund T, Korsgren O, Aursnes IA, Scholz H, Foss A. Sustained Reversal of Diabetes Following Islet Transplantation to Striated Musculature in the Rat. Journal of Surgical Research in press. The paper is not available in DUO. The published version is available at: https://doi.org/10.1016/j.jss.2008.11.009 |